Status:
COMPLETED
Cohort of HIV-infected Children
Lead Sponsor:
ANRS, Emerging Infectious Diseases
Conditions:
Children Infected by HIV
Eligibility:
All Genders
Up to 13 years
Brief Summary
The purpose of this study is to describe the conditions of access to early treatment of children infected with HIV, their management on the long-term, and impact on growth, clinical and immunovirologi...
Detailed Description
The CO10 EPF paediatric cohort includes therapeutic, clinical and biological detailed questionnaires. The data are collected by the doctors every three months to 2 years and then every 6 months until ...
Eligibility Criteria
Inclusion
- HIV-infected children born to mothers included in ANRS-CO1 EPF or children under the age of 13 newly entered in care management with no prior antiretroviral therapy, whose mother was or not included in ANRS-CO1 EPF
Exclusion
- \>= 13 years
- refusal of legal representative of the child
- antiretroviral therapy started before the entry in care management
- care management for over 6 months before inclusion
Key Trial Info
Start Date :
July 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2020
Estimated Enrollment :
812 Patients enrolled
Trial Details
Trial ID
NCT03235258
Start Date
July 1 2004
End Date
June 1 2020
Last Update
April 13 2021
Active Locations (23)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Angers
Angers, France
2
CHU Hôpital Jean Minjoz
Besançon, France
3
Hôpital Jean Verdier
Bondy, France
4
Centre Hospitalier Pellegrin
Bordeaux, France